DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
25.13B
Market cap25.13B
Price-Earnings ratio
26.36
Price-Earnings ratio26.36
Dividend yield
Dividend yield
Average volume
6.01M
Average volume6.01M
High today
$65.17
High today$65.17
Low today
$61.27
Low today$61.27
Open price
$61.70
Open price$61.70
Volume
13.51M
Volume13.51M
52 Week high
$89.98
52 Week high$89.98
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $64.92, giving the company a market capitalization of 25.13B. It carries a P/E multiple of 26.36.

On 2026-05-18, DexCom(DXCM) stock moved within a range of $61.27 to $65.17. With shares now at $64.92, the stock is trading +6.0% above its intraday low and -0.4% below the session's peak.

Trading volume for DexCom(DXCM) stock has reached 13.51M, versus its average volume of 6.01M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

DXCM News

Investing.com 13h
Canaccord lowers DexCom stock price target on margin outlook - Investing.com

...

Canaccord lowers DexCom stock price target on margin outlook - Investing.com
TipRanks 13h
DexCom announces Dexcom Flex in Germany

DexCom (DXCM) announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new...

Nasdaq 2d
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose...

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
12.5%
Sell
3.1%

More DXCM News

Simply Wall St 3d
Is It Time To Revisit DexCom After Share Price Weakness And DCF Upside?

Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio? The shar...

Is It Time To Revisit DexCom After Share Price Weakness And DCF Upside?
Benzinga 3d
Diabetes Tech Player DexCom Lays Out 2030 Growth Vision

Company Highlights Long-Term Margin Expansion Goals The diabetes technology company in an SEC filing said it expects organic revenue growth of more than 10% an...

Diabetes Tech Player DexCom Lays Out 2030 Growth Vision
TipRanks 3d
Why Is Dexcom Stock Soaring Today?

Dexcom (DXCM) stock jumped about 8% on Friday, at the time of writing, as activist investor Elliott Investment Management took a stake in the maker of continuou...

TipRanks 4d
Dexcom Unveils 2030 Targets and $1 Billion Buyback

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 4d
Is DexCom’s Governance Shake-Up Enough To Unlock Its Automated Insulin Ecosystem Potential?

Earlier this month, DexCom outlined governance changes ahead of its 2026 Investor Day, agreeing with Elliott Investment Management to recruit two new independen...

Is DexCom’s Governance Shake-Up Enough To Unlock Its Automated Insulin Ecosystem Potential?
24/7 Wall St. 7d
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More By Lee Jac...

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.